58 Biggest Movers From Yesterday
Gainers
Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs
after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe is no long active.
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Here's a roundup of top developments in the biotech space over the last 24 hours.
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech’s Vaccine For Children
Here's a roundup of top developments in the biotech space over the last 24 hours:
NANOBIOTIX Late Sunday Highlighted Presentation Of Phase 1 Expansion Data Evaluating Nbtxr3 As Single Agent Activated By Radiotherapy At Annual Meeting of the American Society for Radiation Oncology
Data presented by Professor Christophe Le Tourneau at the 2021 Annual Meeting of the American Society for Radiation Oncology
First survival data from Phase I Dose Expansion in tough-to-treat elderly and frail LA-HNSCC
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength.
